Eczema/Atopic Dermatitis

Eczema involves chronic inflammation that leaves the skin covered in scaly, itchy lesions. These lesions crack and damage the skin’s outer barrier, which makes it more sensitive and prone to infection.

Dry skin, severe itchiness, red or brownish-gray patches on the hands, feet, ankles, wrists, neck, upper chest, eyelids, face, scalp, and inside the bend of elbows/knees, small bumps, thickened or cracked skin, and damage from scratching.

Asthma, depression, and anxiety.

Eczema tends to first develop in people before the age of 5 and typically persists for years after, manifesting in periodic flare-ups. Studies have found that having a family history of eczema, allergies, hay fever, or asthma can increase the risk of developing this condition. Environmental factors (such as cold, dry weather conditions, skin irritants, or allergies) can also trigger flare-ups. Females are believed to be at a higher risk. Additionally, African Americans are more at risk than other races.

• Prevalence of excessive daytime sleepiness among patients with atopic dermatitis (2023)
• Novel insights into atopic dermatitis (2023)
• Biomarkers in atopic dermatitis (2023)
• Comorbidities of atopic dermatitis-what does the evidence say? (2023)
• Mendelian Randomization Analysis Reveals a Complex Genetic Interplay among Atopic Dermatitis, Asthma, and Gastroesophageal Reflux Disease (2023)
• Prevalence of and association between atopic dermatitis and food sensitivity, food allergy and challenge-proven food allergy: A systematic review and meta-analysis (2023)

Improving Equitable Care in Atopic Dermatitis: Incorporating Insights From Patients With Skin of Color

Tune into this insightful discussion in which renowned dermatologists examine the diagnosis and treatment of atopic dermatitis in patients with skin of color. These experts will share pivotal insights gained from a recent survey of patients conducted in partnership with the Allergy & Asthma Network. They will also explore differences in the presentation of AD in darker skin types, the evolving pharmacologic landscape, and strategies to improve equitable access to care. Effective approaches to engage in shared decision-making and personalize treatment among diverse patients will also be explored.

This activity is delivered by PRIME Education.